Longeveron Inc. (NASDAQ: LGVN)
$4.13
+0.6100 ( +17.33% ) 27.6M
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Market Data
Open
$4.13
Previous close
$3.52
Volume
27.6M
Market cap
$39.56M
Day range
$3.55 - $4.95
52 week range
$0.77 - $36.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 25, 2024 |
pre | Proxies and info statements | 3 | Jan 25, 2024 |
4 | Insider transactions | 1 | Jan 25, 2024 |
4 | Insider transactions | 1 | Jan 11, 2024 |
4 | Insider transactions | 1 | Jan 02, 2024 |
4 | Insider transactions | 1 | Dec 29, 2023 |
8-k | 8K-related | 12 | Dec 28, 2023 |
4 | Insider transactions | 1 | Dec 26, 2023 |
4 | Insider transactions | 1 | Dec 26, 2023 |
4 | Insider transactions | 1 | Dec 26, 2023 |